Flow Traders U.S.’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRN
Flow Traders U.S.'s IBRN Position: Q2 2025 in Review
Flow Traders U.S. sold out of iShares Neuroscience and Healthcare ETF (IBRN) in Q2 2025, closing a stake of 11,615 shares — an estimated $260K sold.
Flow Traders U.S. first reported a position in IBRN in Q3 2022 and held it in 10 quarters. The position peaked at $1.17M in Q3 2022. 4 funds tracked by Wall St. Rank hold IBRN as of Q2 2025.
- Flow Traders U.S. reported no remaining iShares Neuroscience and Healthcare ETF position as of Q2 2025 after selling out during the quarter.
- Flow Traders U.S. sold 11,615 iShares Neuroscience and Healthcare ETF shares in Q2 2025, an estimated $260K.
- Flow Traders U.S. first reported a position in iShares Neuroscience and Healthcare ETF in Q3 2022 and held it in 10 quarters.
- Flow Traders U.S.'s iShares Neuroscience and Healthcare ETF position peaked at $1.17M in Q3 2022.
- 4 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q2 2025.
Based on Flow Traders U.S.'s 13F filing for Q2 2025, filed 13 Aug 2025.